Source: ERS Lung Science Conference 2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
James D. Chalmers (Dundee (Angus), United Kingdom). The microbiome in bronchiectasis. ERS Lung Science Conference 2019

Member's Comments

No comment yet.

Related content which might interest you: The fungal microbiome and its role in bronchiectasis Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 The microbiome in IPF Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)" Year: 2014 Immunometabolic markers and the sputum microbiome in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Gut microbiome in COPD Source: International Congress 2016 – Microbiome in health and in disease Year: 2016 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Implications of the microbiome and mycobiome in cystic fibrosis Source: International Congress 2015 – Microbial impacts at different human ages Year: 2015 The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis Source: Eur Respir J 2013; 41: 991-993 Year: 2013 Bacterial dysbiosis in pediatric lung diseases such as asthma and CF Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future Year: 2020 The pulmonary bacterial and fungal microbiota in sarcoidosis patients. Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 The cystic fibrosis lower airways microbial metagenome Source: ERJ Open Res 2016: 00096-2015 Year: 2016 Lung microbiome dysbiosis is associated with mortality in COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020